Cargando…

Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology

INTRODUCTION: Patients with primary adrenal insufficiency (PAI) suffer from increased risk of infection, adrenal crises and have a higher mortality rate. Such dismal outcomes have been inferred to immune cell dysregulation because of unphysiological cortisol replacement. As the immune landscape of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowotny, Hanna F., Marchant Seiter, Thomas, Ju, Jing, Gottschlich, Adrian, Schneider, Holger, Zopp, Stephanie, Vogel, Frederick, Tschaidse, Lea, Auer, Matthias K., Lottspeich, Christian, Kobold, Sebastian, Rothenfusser, Simon, Beuschlein, Felix, Reincke, Martin, Braun, Leah, Reisch, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690587/
https://www.ncbi.nlm.nih.gov/pubmed/38045693
http://dx.doi.org/10.3389/fimmu.2023.1275828
_version_ 1785152552612921344
author Nowotny, Hanna F.
Marchant Seiter, Thomas
Ju, Jing
Gottschlich, Adrian
Schneider, Holger
Zopp, Stephanie
Vogel, Frederick
Tschaidse, Lea
Auer, Matthias K.
Lottspeich, Christian
Kobold, Sebastian
Rothenfusser, Simon
Beuschlein, Felix
Reincke, Martin
Braun, Leah
Reisch, Nicole
author_facet Nowotny, Hanna F.
Marchant Seiter, Thomas
Ju, Jing
Gottschlich, Adrian
Schneider, Holger
Zopp, Stephanie
Vogel, Frederick
Tschaidse, Lea
Auer, Matthias K.
Lottspeich, Christian
Kobold, Sebastian
Rothenfusser, Simon
Beuschlein, Felix
Reincke, Martin
Braun, Leah
Reisch, Nicole
author_sort Nowotny, Hanna F.
collection PubMed
description INTRODUCTION: Patients with primary adrenal insufficiency (PAI) suffer from increased risk of infection, adrenal crises and have a higher mortality rate. Such dismal outcomes have been inferred to immune cell dysregulation because of unphysiological cortisol replacement. As the immune landscape of patients with different types of PAI has not been systematically explored, we set out to immunophenotype PAI patients with different causes of glucocorticoid (GC) deficiency. METHODS: This cross-sectional single center study includes 28 patients with congenital adrenal hyperplasia (CAH), 27 after bilateral adrenalectomy due to Cushing’s syndrome (BADx), 21 with Addison’s disease (AD) and 52 healthy controls. All patients with PAI were on a stable GC replacement regimen with a median dose of 25 mg hydrocortisone per day. Peripheral blood mononuclear cells were isolated from heparinized blood samples. Immune cell subsets were analyzed using multicolor flow cytometry after four-hour stimulation with phorbol myristate acetate and ionomycin. Natural killer (NK-) cell cytotoxicity and clock gene expression were investigated. RESULTS: The percentage of T helper cell subsets was downregulated in AD patients (Th1 p = 0.0024, Th2 p = 0.0157, Th17 p < 0.0001) compared to controls. Cytotoxic T cell subsets were reduced in AD (Tc1 p = 0.0075, Tc2 p = 0.0154) and CAH patients (Tc1 p = 0.0055, Tc2 p = 0.0012) compared to controls. NKCC was reduced in all subsets of PAI patients, with smallest changes in CAH. Degranulation marker CD107a expression was upregulated in BADx and AD, not in CAH patients compared to controls (BADx p < 0.0001; AD p = 0.0002). In contrast to NK cell activating receptors, NK cell inhibiting receptor CD94 was upregulated in BADx and AD, but not in CAH patients (p < 0.0001). Although modulation in clock gene expression could be confirmed in our patient subgroups, major interindividual-intergroup dissimilarities were not detected. DISCUSSION: In patients with different etiologies of PAI, distinct differences in T and NK cell-phenotypes became apparent despite the use of same GC preparation and dose. Our results highlight unsuspected differences in immune cell composition and function in PAI patients of different causes and suggest disease-specific alterations that might necessitate disease-specific treatment.
format Online
Article
Text
id pubmed-10690587
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106905872023-12-02 Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology Nowotny, Hanna F. Marchant Seiter, Thomas Ju, Jing Gottschlich, Adrian Schneider, Holger Zopp, Stephanie Vogel, Frederick Tschaidse, Lea Auer, Matthias K. Lottspeich, Christian Kobold, Sebastian Rothenfusser, Simon Beuschlein, Felix Reincke, Martin Braun, Leah Reisch, Nicole Front Immunol Immunology INTRODUCTION: Patients with primary adrenal insufficiency (PAI) suffer from increased risk of infection, adrenal crises and have a higher mortality rate. Such dismal outcomes have been inferred to immune cell dysregulation because of unphysiological cortisol replacement. As the immune landscape of patients with different types of PAI has not been systematically explored, we set out to immunophenotype PAI patients with different causes of glucocorticoid (GC) deficiency. METHODS: This cross-sectional single center study includes 28 patients with congenital adrenal hyperplasia (CAH), 27 after bilateral adrenalectomy due to Cushing’s syndrome (BADx), 21 with Addison’s disease (AD) and 52 healthy controls. All patients with PAI were on a stable GC replacement regimen with a median dose of 25 mg hydrocortisone per day. Peripheral blood mononuclear cells were isolated from heparinized blood samples. Immune cell subsets were analyzed using multicolor flow cytometry after four-hour stimulation with phorbol myristate acetate and ionomycin. Natural killer (NK-) cell cytotoxicity and clock gene expression were investigated. RESULTS: The percentage of T helper cell subsets was downregulated in AD patients (Th1 p = 0.0024, Th2 p = 0.0157, Th17 p < 0.0001) compared to controls. Cytotoxic T cell subsets were reduced in AD (Tc1 p = 0.0075, Tc2 p = 0.0154) and CAH patients (Tc1 p = 0.0055, Tc2 p = 0.0012) compared to controls. NKCC was reduced in all subsets of PAI patients, with smallest changes in CAH. Degranulation marker CD107a expression was upregulated in BADx and AD, not in CAH patients compared to controls (BADx p < 0.0001; AD p = 0.0002). In contrast to NK cell activating receptors, NK cell inhibiting receptor CD94 was upregulated in BADx and AD, but not in CAH patients (p < 0.0001). Although modulation in clock gene expression could be confirmed in our patient subgroups, major interindividual-intergroup dissimilarities were not detected. DISCUSSION: In patients with different etiologies of PAI, distinct differences in T and NK cell-phenotypes became apparent despite the use of same GC preparation and dose. Our results highlight unsuspected differences in immune cell composition and function in PAI patients of different causes and suggest disease-specific alterations that might necessitate disease-specific treatment. Frontiers Media S.A. 2023-11-15 /pmc/articles/PMC10690587/ /pubmed/38045693 http://dx.doi.org/10.3389/fimmu.2023.1275828 Text en Copyright © 2023 Nowotny, Marchant Seiter, Ju, Gottschlich, Schneider, Zopp, Vogel, Tschaidse, Auer, Lottspeich, Kobold, Rothenfusser, Beuschlein, Reincke, Braun and Reisch https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Nowotny, Hanna F.
Marchant Seiter, Thomas
Ju, Jing
Gottschlich, Adrian
Schneider, Holger
Zopp, Stephanie
Vogel, Frederick
Tschaidse, Lea
Auer, Matthias K.
Lottspeich, Christian
Kobold, Sebastian
Rothenfusser, Simon
Beuschlein, Felix
Reincke, Martin
Braun, Leah
Reisch, Nicole
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
title Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
title_full Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
title_fullStr Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
title_full_unstemmed Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
title_short Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
title_sort major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690587/
https://www.ncbi.nlm.nih.gov/pubmed/38045693
http://dx.doi.org/10.3389/fimmu.2023.1275828
work_keys_str_mv AT nowotnyhannaf majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT marchantseiterthomas majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT jujing majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT gottschlichadrian majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT schneiderholger majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT zoppstephanie majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT vogelfrederick majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT tschaidselea majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT auermatthiask majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT lottspeichchristian majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT koboldsebastian majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT rothenfussersimon majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT beuschleinfelix majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT reinckemartin majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT braunleah majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology
AT reischnicole majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology